Why Allkem, IGO, Northern Star, and Race Oncology shares are racing higher

These ASX shares are ending the week strongly.

| More on:
Rising share price chart.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. At the time of writing, the benchmark index is up 0.4% to 7,351.1 points.

Four ASX shares that are climbing more than most today are listed below. Here's why they are racing higher:

Allkem Ltd (ASX: AKE)

The Allkem share price is up 4.5% to $11.55. This is despite there being no news out of the lithium miner. However, it is worth noting that a number of lithium shares are ending the week strongly. In addition, Goldman Sachs named Allkem as one of two ASX lithium shares to buy earlier this week.

IGO Ltd (ASX: IGO)

The IGO share price is up 5% to $13.38. This morning, this green metals miner revealed that it has secured land to build its proposed Integrated Battery Material Facility (IBM Facility). The project's development will see a downstream nickel refinery integrated with a plant producing high-value nickel dominant precursor cathode active material.

Northern Star Resources Ltd (ASX: NST)

The Northern Star share price is up 4% to $14.36. Investors have been buying Northern Star and other gold miners today after the price of the precious metal rose to a new one-year high. This has seen the S&P/ASX All Ordinaries Gold index rise a sizeable 2.9% this afternoon.

Race Oncology Ltd (ASX: RAC)

The Race Oncology share price is up 6.5% to $1.87. This has been driven by the release of a detailed commercial assessment of the market potential for its Zantrene product as a cardio-protective agent or dual cardio-protective and anti-cancer agent in breast, endometrial, and ovarian cancers. Management sees scope to generate revenue as high as US$8 billion a year from the product.

Motley Fool contributor James Mickleboro has positions in Allkem. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

Why Develop Global, Empire Energy, Mineral Resources, and Pilbara Minerals shares are rising

These shares are ending the week strongly. But why?

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX biotech shares rocketing more than 40% on big news

These two ASX healthcare companies have exciting news for investors today.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Aurora Labs, Coronado Global, Latin Resources, and Newmont shares are rising

These shares are having a better day than most. But why?

Read more »

A woman is excited as she reads the latest rumour on her phone.
Share Gainers

Why Catalyst Metals, Ora Banda, Spartan Resources, and TechnologyOne shares are rising today

These shares are overcoming the market weakness and pushing higher. But why?

Read more »

Lab worker puts hands in the air and dances around
Healthcare Shares

Guess which ASX healthcare stock just rocketed 46% on major news!

Investors are sending this ASX healthcare stock flying higher on Wednesday. But why?

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why Arafura, Dropsuite, Spartan Resources, and Universal Store shares are pushing higher

These shares are having a strong session on Tuesday. But why?

Read more »

Man on a laptop thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield-eque start to the trading week this Monday.

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Healthcare Shares

If you invested $5,000 in this ASX pharmaceuticals stock a year ago, you'd have $34,711 now!

Just how lucky have investors been with this stock?

Read more »